For eight decades, JNCI has been among the leading journals in oncology and cancer sciences. JNCI is an international peer-reviewed and impactful journal which publishes manuscripts describing novel findings of significance in cancer research. Published research often has a particular focus on clinical, epidemiologic, behavioral, and health outcomes studies. There are many reasons to submit your research to JNCI, including a rigorous but rapid review process of submitted research, so that findings of high scientific and global medical interest can be published with minimum delay.
Editor's Choice & Editorials
Background Establishing whether women with major depressive disorder who develop breast cancer have poor outcomes is key to optimizing care for this population. To this end, we examined associations between major depressive disorder and breast cancer recurrence and mortality. Methods Using medical record data from the US Department of Veterans Affairs health-care system, we established a ...
Background Most breast biopsies are diagnosed as benign breast disease, with 1.5- to 4-fold increased breast cancer risk. Apart from pathologic diagnoses of atypical hyperplasia, few factors aid in breast cancer risk assessment of these patients. We assessed whether a 313–single nucleotide variation (formerly single-nucleotide polymorphism) polygenic risk score stratifies risk of benign breast ...
Background Surgery with neoadjuvant and adjuvant chemotherapy represents the standard of care for extremity osteosarcoma despite a lack of high-quality evidence for its use, and trial evidence that suggests upfront surgery may result in better outcomes. This study estimated the difference in overall survival for the standard of care (neoadjuvant first) vs upfront surgery first followed by ...
Background Many uninsured patients do not receive Medicaid coverage until a cancer diagnosis, potentially delaying access to care for early cancer detection and treatment. We examined the association of Medicaid enrollment timing and patterns with survival among children, adolescents, and young adults with diagnosed blood cancers, where disease onset can be acute and early detection is critical. ...
Editor-in-Chief
Dr. Eduardo L. Franco
Editorial Board
JOURNAL IMPACT FACTOR
10.0
5 YEAR IMPACT FACTOR
10.5
Opioids and Cancer Collection
Explore a selection of articles from JNCI and JNCI Cancer Spectrum on opioid use in cancer patients and survivors.
Read now.
Diversity, Equity, and Inclusion Collection
As a part of their Diversity, Equity, and Inclusion initiative, JNCI and JNCI Cancer Spectrum have curated a collection of articles that foreground diversity, equity, and inclusion in their research.
Read now.
COVID-19 Collection
JNCI and JNCI Cancer Spectrum have published a number of peer-reviewed, cancer-relevant manuscripts related to the pandemic. Explore the freely available articles in this collection.
Read now.
Diversity, Equity, and Inclusion for the JNCI Journals
In 2022, the JNCI journals launched a DEI initiative, committing to increase diversity and inclusion of underrepresented groups in the peer review process and research dissemination. 1 year on, the teams provide an update. Read the editorial here.
JNCI Cancer Spectrum
JNCI Cancer Spectrum is a peer-reviewed, open-access journal. It publishes manuscripts that describe new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research.
Learn more about the journal
JNCI Monographs
Have you read the latest publication from JNCI Monographs?
Read the current issue and explore the archive
Stay up to date with the latest news and content from JNCI by visiting our Facebook page.
Email alerts
Register to receive table of contents email alerts as soon as new issues of JNCI: Journal of the National Cancer Institute are published online.
Sign up
Developing countries initiative
Your institution could be eligible to free or deeply discounted online access to JNCI: Journal of the National Cancer Institute through the Oxford Developing Countries Initiative.
Find out more
Committee on Publication Ethics (COPE)
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE)
publicationethics.org
Recommend to your library
Fill out our simple online form to recommend JNCI: Journal of the National Cancer Institute to your library.
Recommend now
Author resources
Learn about how to submit your article, our publishing process, and tips on how to promote your article.
Find out more
